Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

Angelika Bierhaus, Thomas Fleming, Stoyan Stoyanov, Andreas Leffler, Alexandru Babes, Cristian Neacsu, Susanne K. Sauer, Mirjam Eberhardt, Martina Schnölzer, Felix Lasischka, Winfried L. Neuhuber, Tatjana I. Kichko, Ilze Konrade, Ralf Elvert, Walter Mier, Valdis Pirags, Ivan K. Lukic, Michael Morcos, Thomas Dehmer, Naila RabbaniPaul J. Thornalley, Diane Edelstein, Carla Nau, Josephine Forbes, Per M. Humpert, Markus Schwaninger, Dan Ziegler, David M. Stern, Mark E. Cooper, Uwe Haberkorn, Michael Brownlee, Peter W. Reeh, Peter P. Nawroth

Research output: Contribution to journalArticle

247 Citations (Scopus)

Abstract

This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na v 1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na v 1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na v 1.8 knockout (Scn10 -/-) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.

Original languageEnglish (US)
Pages (from-to)926-933
Number of pages8
JournalNature Medicine
Volume18
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Pyruvaldehyde
Nociceptors
Diabetic Neuropathies
Hyperalgesia
Neurons
Medical problems
Pain
Neurosecretion
Voltage-Gated Sodium Channels
Calcitonin Gene-Related Peptide
Genetic Models
Neural Conduction
Sensory Receptor Cells
Cyclooxygenase 2
Post Translational Protein Processing
Streptozocin
Metabolites
Knockout Mice
Brain
Blood

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., ... Nawroth, P. P. (2012). Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nature Medicine, 18(6), 926-933. https://doi.org/10.1038/nm.2750

Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. / Bierhaus, Angelika; Fleming, Thomas; Stoyanov, Stoyan; Leffler, Andreas; Babes, Alexandru; Neacsu, Cristian; Sauer, Susanne K.; Eberhardt, Mirjam; Schnölzer, Martina; Lasischka, Felix; Neuhuber, Winfried L.; Kichko, Tatjana I.; Konrade, Ilze; Elvert, Ralf; Mier, Walter; Pirags, Valdis; Lukic, Ivan K.; Morcos, Michael; Dehmer, Thomas; Rabbani, Naila; Thornalley, Paul J.; Edelstein, Diane; Nau, Carla; Forbes, Josephine; Humpert, Per M.; Schwaninger, Markus; Ziegler, Dan; Stern, David M.; Cooper, Mark E.; Haberkorn, Uwe; Brownlee, Michael; Reeh, Peter W.; Nawroth, Peter P.

In: Nature Medicine, Vol. 18, No. 6, 06.2012, p. 926-933.

Research output: Contribution to journalArticle

Bierhaus, A, Fleming, T, Stoyanov, S, Leffler, A, Babes, A, Neacsu, C, Sauer, SK, Eberhardt, M, Schnölzer, M, Lasischka, F, Neuhuber, WL, Kichko, TI, Konrade, I, Elvert, R, Mier, W, Pirags, V, Lukic, IK, Morcos, M, Dehmer, T, Rabbani, N, Thornalley, PJ, Edelstein, D, Nau, C, Forbes, J, Humpert, PM, Schwaninger, M, Ziegler, D, Stern, DM, Cooper, ME, Haberkorn, U, Brownlee, M, Reeh, PW & Nawroth, PP 2012, 'Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy', Nature Medicine, vol. 18, no. 6, pp. 926-933. https://doi.org/10.1038/nm.2750
Bierhaus, Angelika ; Fleming, Thomas ; Stoyanov, Stoyan ; Leffler, Andreas ; Babes, Alexandru ; Neacsu, Cristian ; Sauer, Susanne K. ; Eberhardt, Mirjam ; Schnölzer, Martina ; Lasischka, Felix ; Neuhuber, Winfried L. ; Kichko, Tatjana I. ; Konrade, Ilze ; Elvert, Ralf ; Mier, Walter ; Pirags, Valdis ; Lukic, Ivan K. ; Morcos, Michael ; Dehmer, Thomas ; Rabbani, Naila ; Thornalley, Paul J. ; Edelstein, Diane ; Nau, Carla ; Forbes, Josephine ; Humpert, Per M. ; Schwaninger, Markus ; Ziegler, Dan ; Stern, David M. ; Cooper, Mark E. ; Haberkorn, Uwe ; Brownlee, Michael ; Reeh, Peter W. ; Nawroth, Peter P. / Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. In: Nature Medicine. 2012 ; Vol. 18, No. 6. pp. 926-933.
@article{e15726d4fc0047e0946790e2e25c5411,
title = "Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy",
abstract = "This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na v 1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na v 1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na v 1.8 knockout (Scn10 -/-) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.",
author = "Angelika Bierhaus and Thomas Fleming and Stoyan Stoyanov and Andreas Leffler and Alexandru Babes and Cristian Neacsu and Sauer, {Susanne K.} and Mirjam Eberhardt and Martina Schn{\"o}lzer and Felix Lasischka and Neuhuber, {Winfried L.} and Kichko, {Tatjana I.} and Ilze Konrade and Ralf Elvert and Walter Mier and Valdis Pirags and Lukic, {Ivan K.} and Michael Morcos and Thomas Dehmer and Naila Rabbani and Thornalley, {Paul J.} and Diane Edelstein and Carla Nau and Josephine Forbes and Humpert, {Per M.} and Markus Schwaninger and Dan Ziegler and Stern, {David M.} and Cooper, {Mark E.} and Uwe Haberkorn and Michael Brownlee and Reeh, {Peter W.} and Nawroth, {Peter P.}",
year = "2012",
month = "6",
doi = "10.1038/nm.2750",
language = "English (US)",
volume = "18",
pages = "926--933",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

AU - Bierhaus, Angelika

AU - Fleming, Thomas

AU - Stoyanov, Stoyan

AU - Leffler, Andreas

AU - Babes, Alexandru

AU - Neacsu, Cristian

AU - Sauer, Susanne K.

AU - Eberhardt, Mirjam

AU - Schnölzer, Martina

AU - Lasischka, Felix

AU - Neuhuber, Winfried L.

AU - Kichko, Tatjana I.

AU - Konrade, Ilze

AU - Elvert, Ralf

AU - Mier, Walter

AU - Pirags, Valdis

AU - Lukic, Ivan K.

AU - Morcos, Michael

AU - Dehmer, Thomas

AU - Rabbani, Naila

AU - Thornalley, Paul J.

AU - Edelstein, Diane

AU - Nau, Carla

AU - Forbes, Josephine

AU - Humpert, Per M.

AU - Schwaninger, Markus

AU - Ziegler, Dan

AU - Stern, David M.

AU - Cooper, Mark E.

AU - Haberkorn, Uwe

AU - Brownlee, Michael

AU - Reeh, Peter W.

AU - Nawroth, Peter P.

PY - 2012/6

Y1 - 2012/6

N2 - This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na v 1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na v 1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na v 1.8 knockout (Scn10 -/-) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.

AB - This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na v 1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na v 1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na v 1.8 knockout (Scn10 -/-) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=84862020461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862020461&partnerID=8YFLogxK

U2 - 10.1038/nm.2750

DO - 10.1038/nm.2750

M3 - Article

C2 - 22581285

AN - SCOPUS:84862020461

VL - 18

SP - 926

EP - 933

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 6

ER -